Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages

Changjian Zhu,Ruilin Zheng,Xu Han,Ziwen Tang,Feng Li,Xinrong Hu,Ruoni Lin,Jiani Shen,Qiaoqiao Pei,Rong Wang,Guangyan Wei,Zhenwei Peng,Wei Chen,Zhou Liang,Yi Zhou
DOI: https://doi.org/10.1038/s41419-024-06785-5
2024-06-06
Cell Death and Disease
Abstract:Integrin αvβ6 holds promise as a therapeutic target for organ fibrosis, yet targeted therapies are hampered by concerns over inflammatory-related side effects. The role of αvβ6 in renal inflammation remains unknown, and clarifying this issue is crucial for αvβ6-targeted treatment of chronic kidney disease (CKD). Here, we revealed a remarkable positive correlation between overexpressed αvβ6 in proximal tubule cells (PTCs) and renal inflammation in CKD patients and mouse models. Notably, knockout of αvβ6 not only significantly alleviated renal fibrosis but also reduced inflammatory responses in mice, especially the infiltration of pro-inflammatory macrophages. Furthermore, conditional knockout of αvβ6 in PTCs in vivo and co-culture of PTCs with macrophages in vitro showed that depleting αvβ6 in PTCs suppressed the migration and pro-inflammatory differentiation of macrophages. Screening of macrophage activators showed that αvβ6 in PTCs activates macrophages via secreting IL-34. IL-34 produced by PTCs was significantly diminished by αvβ6 silencing, and reintroduction of IL-34 restored macrophage activities, while anti-IL-34 antibody restrained macrophage activities enhanced by αvβ6 overexpression. Moreover, RNA-sequencing of PTCs and verification experiments demonstrated that silencing αvβ6 in PTCs blocked hypoxia-stimulated IL-34 upregulation and secretion by inhibiting YAP expression, dephosphorylation, and nuclear translocation, which resulted in the activation of Hippo signaling. While application of a YAP agonist effectively recurred IL-34 production by PTCs, enhancing the subsequent macrophage migration and activation. Besides, reduced IL-34 expression and YAP activation were also observed in global or PTCs-specific αvβ6-deficient injured kidneys. Collectively, our research elucidates the pro-inflammatory function and YAP/IL-34/macrophage axis-mediated mechanism of αvβ6 in renal inflammation, providing a solid rationale for the use of αvβ6 inhibition to treat kidney inflammation and fibrosis.
cell biology
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to explore the specific role and mechanism of integrin αvβ6 in kidney inflammation in chronic kidney disease (CKD). Specifically, the researchers hope to answer the following key questions: 1. **The role of integrin αvβ6 in kidney inflammation**: Although it is known that integrin αvβ6 plays an important role in fibrosis of multiple organs, its specific function in kidney inflammation remains unclear. The researchers hope to reveal the exact role of integrin αvβ6 in kidney inflammation through this study. 2. **The relationship between integrin αvβ6 and pro - inflammatory macrophages**: The researchers want to know whether integrin αvβ6 exacerbates kidney inflammation by affecting the infiltration and differentiation of pro - inflammatory macrophages. This helps to understand how integrin αvβ6 mediates the kidney inflammatory response. 3. **The mechanism by which integrin αvβ6 regulates IL - 34 expression**: The researchers attempt to reveal how integrin αvβ6 promotes macrophage migration and activation by regulating the expression and secretion of IL - 34, thereby leading to kidney inflammation and fibrosis. 4. **The role of the Hippo/YAP signaling pathway in integrin αvβ6 regulation**: The researchers want to verify whether integrin αvβ6 up - regulates the expression of IL - 34 by inhibiting YAP protein phosphorylation and nuclear translocation in the Hippo signaling pathway, and then affects kidney inflammation and fibrosis. ### Research background Chronic kidney disease (CKD) is a global public health threat with high morbidity and mortality, which seriously affects the quality of life of patients. Renal fibrosis is the main pathological process driving the progression of CKD, but current treatment methods mainly target symptoms and fail to directly improve renal fibrosis. Therefore, it is particularly urgent to develop safe and effective treatment methods to stop this fatal process. Integrin αvβ6, as a transmembrane receptor, plays an important role in cell adhesion and extracellular matrix communication. Previous studies have shown that integrin αvβ6 is up - regulated in the fibrosis processes of organs such as the lung, liver, and kidney, and promotes fibrosis by activating transforming growth factor - β1 (TGF - β1). However, clinical trials targeting integrin αvβ6 have been frustrated due to severe inflammation - related side effects, which suggests that further research on its role in kidney inflammation is needed. ### Research significance This study provides a theoretical basis for the development of treatment strategies targeting integrin αvβ6 by revealing the specific role and mechanism of integrin αvβ6 in kidney inflammation. In particular, the study found that integrin αvβ6 promotes macrophage infiltration and pro - inflammatory differentiation by activating the YAP/IL - 34 axis, ultimately exacerbating kidney inflammation and fibrosis. These findings not only help to deeply understand the mechanism of kidney inflammation, but also provide important clues for the development of new treatment strategies.